Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-13

FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Solco Healthcare LLC)

View source ↗

Summary

FDA approved a supplemental application to market a generic candesartan cilexetil and hydrochlorothiazide combination product for hypertension, from Solco Healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Candesartan Cilexetil and Hydrochlorothiazide (Candesartan cilexetil and hydrochlorothiazide)

Snippet

SUPPL AP for CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE (CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE)